Flatiron Health (Roche) / flatiron.com
AI-powered oncology data and software platform that curates real-world evidence from cancer patient records to accelerate clinical research, drug development, and quality improvement in cancer care.
Pricing
Free
Free plan
No
Category
Developer Tools
Platforms
2
Free plan
No
API access
No
Open source
No
Platforms
2
Flatiron Health is an oncology-focused health technology company (subsidiary of Roche) that curates real-world evidence from electronic health records of cancer patients to support pharmaceutical research, regulatory submissions, and cancer centre quality improvement.
The core asset is Flatiron's longitudinal oncology database — structured data from cancer patient records at over 280 cancer clinics representing more than 9 million US cancer patients, curated by abstractors and AI to extract structured clinical data from unstructured notes, pathology reports, and treatment records.
Natural language processing extracts structured clinical data — tumour characteristics, treatment regimens, response assessments, adverse events — from free-text clinical notes where data critical for research is buried in narrative form. This curation transforms unusable unstructured clinical notes into structured datasets for research.
Real-world evidence (RWE) generated from Flatiron's curated data supports regulatory submissions to FDA for drug approvals, health technology assessments, and post-market surveillance studies — with FDA having accepted Flatiron real-world evidence in multiple regulatory submissions.
For cancer centres, Flatiron's OncoEMR electronic health record system captures structured oncology data at the point of care, feeding the network database and enabling quality improvement analytics for participating centres.
Flatiron Health AI runs as document analysis llm software built around text and document workflows. Users typically start with a prompt, upload, or connected data source, and the underlying model handles the heavy lifting before returning a result you can refine or export. It's available on web and api.
The capabilities that matter most for teams evaluating Flatiron Health AI.
Structured real-world evidence from 9 million+ US cancer patients curated from EHR records at 280+ cancer clinics, one of the largest regulatory-grade oncology datasets.
Extracts structured clinical data (tumour characteristics, treatments, outcomes) from unstructured clinical notes making this data accessible for research at scale.
Multiple regulatory submissions have used Flatiron real-world evidence, establishing the data quality standards and methodology accepted by FDA for drug development purposes.
Enterprise licensing to pharmaceutical companies and cancer centres. No public pricing. Subsidiary of Roche.
Model
Enterprise
Starting price
Free
Free trial
No
IQVIA Oncology provides competing real-world oncology data. Foundation Medicine (also Roche) provides genomic data complementary to Flatiron's clinical data. Tempus AI (covered, rank 275) provides competing oncology AI with genomics. ConcertAI provides oncology RWE.
A side-by-side look at the closest alternative in this category.
Key facts about model providers, platforms, and team support.
Model Provider
Flatiron Health
Platforms
Web, API
Deployment
Enterprise, SaaS
Integrations
EHR systems, Clinical data systems, Regulatory submission tools, API
Team Collaboration
No
Launch Year
2021
Compliance signals and data-handling notes as reported by the vendor.
HIPAA compliant with BAA. SOC 2 Type II. GDPR compliant for EU deployments. IRB approval for research datasets. FDA-accepted data quality standards.
Patient health data processed under strict HIPAA BAA and applicable research ethics frameworks. De-identification and IRB protocols govern research dataset access.
Editorial Verdict
Flatiron Health is the leading oncology real-world evidence platform for pharmaceutical companies conducting oncology drug development, offering the most FDA-validated US cancer patient real-world database.
Last verified July 24, 2026.
Acquired by Roche in 2018, Flatiron's oncology data has become a critical asset for Roche's pharmaceutical pipeline and for independent pharmaceutical companies conducting oncology research.
Enterprise licensing to pharmaceutical companies and cancer centres. No public pricing. Subsidiary of Roche.
Enterprise licensing to health systems, pharmaceutical companies, and research institutions. No public pricing.
HIPAA compliant with BAA. SOC 2 Type II. GDPR compliant for EU deployments. IRB approval for research datasets. FDA-accepted data quality standards.
HIPAA compliant. SOC 2 Type II. ISO 27001. Patient genomic and clinical data handled under HIPAA protections with appropriate de-identification for research use.
Patient health data processed under strict HIPAA BAA and applicable research ethics frameworks. De-identification and IRB protocols govern research dataset access.
Patient genomic and clinical data processed under HIPAA protections. Research use data is de-identified per HIPAA standards. Enterprise includes comprehensive data handling agreements.
Verified reviews from signed-in users, stored in the backend and averaged into this tool's rating.
Sign in to rate Flatiron Health AI and leave a review.
No other reviews yet — be the first to share how this tool performs in practice.
